Building digital health tools that ship

The Document AI market is projected to grow from USD 17.51 billion in 2026 to USD 35.34 billion by 2031, a 15.1% CAGR (PR Newswire). Most of that spend will land in regulated industries, and healthcare is first in line. Referral letters, discharge summaries, lab PDFs and prior authorisation forms are the raw material of every clinical workflow, and they are exactly what modern AI is finally good at parsing.

The pressure on product teams is to turn that capability into digital health tools clinicians will actually use, without breaking HIPAA, GDPR, or the trust of the doctor holding the tablet.

What are digital health tools

Digital health tools are software products used by patients, clinicians, or payers to capture, interpret, or act on health data. They range from patient facing apps and remote monitoring devices to clinician facing decision support, EHR integrated modules, and back office automation for coding and claims.

The useful distinction is not consumer versus clinical. It is whether the tool sits inside a regulated clinical workflow. A step counter is a wellness app. A digital tool that flags a rising HbA1c trend to a diabetes nurse and writes back into the EHR is a medical device in most jurisdictions, and it has to be built like one.

Where embedded AI actually earns its keep

AI in healthcare software is often pitched as diagnosis. In production, the wins are quieter and more durable.

Document understanding is the obvious one. A GP practice receives a fax, a hospital discharge summary and three lab PDFs for the same patient in a week. Extracting structured problems, medications and results into the record saves hours of admin per clinician per week. That is where the Document AI growth curve is coming from.

Triage and routing is the second. Inbound patient messages, symptom checkers, and nurse hotlines all benefit from a model that can sort urgent from routine and draft a first response for human review. The key word is review. Nothing goes to a patient without a clinician in the loop.

The third is longitudinal pattern detection, especially for chronic disease. Digital health tools for diabetes are a good example: continuous glucose data, meal logs and activity streams are noisy and high volume, and a well trained model can surface the two or three insights a week that actually change a care plan.

Digital mental health tools deserve a different bar

Digital mental health tools are the category most likely to be shipped badly. The temptation is to wrap a general purpose LLM in a chat UI, call it a wellness companion, and let it drift into territory it has no business in.

The engineering job here is guardrails, not model choice. That means explicit crisis detection with hard routing to human clinicians, refusal policies that hold under adversarial prompts, session boundaries, and clear audit trails of every message shown to a user. The American Psychiatric Association has published evaluation frameworks worth reading before a single sprint starts.

It also means measurement. A digital mental health tool that cannot show clinician reviewed outcomes after six months is a liability, not a product.

Digital health tools for patients: the workflow test

The fastest way to kill adoption of digital health tools for patients is to build something that assumes the patient is the primary user. In chronic care, the primary user is usually the clinician or care coordinator on the other side of the data.

A patient facing app that produces a beautiful graph nobody in the clinic can see is dead on arrival. The same app, wired into the EHR with a nurse dashboard that batches ten patients into a fifteen minute review, changes the economics of the whole practice.

The workflow test is simple. For every patient facing feature, name the clinician who consumes the output, the system where they see it, and the time budget they have to act on it. If any of the three is missing, cut the feature.

The compliance surface is the architecture

HIPAA, GDPR, the EU AI Act, and MDR are not a checklist you apply at the end. They shape the architecture from day one.

A few decisions that compound:

• Data residency. EU patient data usually stays in the EU. That constrains model hosting and vendor choice, and it is why a lot of teams end up self hosting open weight models rather than shipping PHI to a US API.
• Audit logging. Every model inference on patient data needs to be reproducible. That means logging the prompt, the model version, the retrieved context, and the output, with retention that matches your clinical records policy.
• Human in the loop. For anything that touches a clinical decision, the UI has to make the human decision the default and the AI output a suggestion. This is a product and legal decision as much as an engineering one.
• Change control. Model updates are software updates. If your model is part of a regulated device, you cannot silently swap it.

A build framework for digital health tools

A practical sequence that tends to work:

1. Name the clinical workflow and the specific minute of the day the tool changes.
2. Identify the data sources and whether you can legally use them for training and inference.
3. Pick the smallest useful AI capability, usually extraction or classification, not generation.
4. Build the human review UI before the model. If clinicians will not use the review surface, the model does not matter.
5. Instrument outcomes from day one: time saved, errors caught, decisions changed.
6. Plan for model and prompt versioning, red teaming, and a rollback path.
7. Only then, scale the model and expand scope.

This is the sequence Devspace uses on AI and data engagements in regulated verticals. Skip a step and you usually pay for it in the second year, when a regulator, a payer, or a chief medical officer asks a question the system cannot answer.

Digital health tools examples worth studying

The examples with staying power tend to share three traits. They embed into an existing workflow rather than replacing it. They keep clinicians in control of any decision that affects a patient. And they measure clinical or operational outcomes, not engagement.

Remote patient monitoring platforms that write structured summaries back into the EHR. Ambient scribes that draft notes for clinician approval. Prior authorisation automation that extracts payer requirements from PDFs and drafts submissions. Diabetes coaching tools that flag pattern changes to a care team rather than nudging the patient directly. None of these are glamorous. All of them are billable, defensible, and durable.

What we bring to healthcare engineering

Devspace is an Oslo based network of 500+ senior software engineers across Europe, embedded directly into client teams. In healthcare that matters for two reasons. Compliance context has to sit inside the engineering team, not be handed to it. And the engineers writing the code need enough seniority to push back on product decisions that would create regulatory risk downstream.

We run engagements as an embedded development team, sourced to your stack, timezone, and clinical domain, usually live in your sprint within two to four weeks. For organisations earlier in the journey, a Fractional CTO can set the AI and data architecture before the first commit.

Digital health tools live or die on the details. The teams that ship the durable ones treat AI as one component of a clinical system, not the product itself.